NYSEMKT: CANF
Can Fite Biopharma Ltd Stock Ownership - Who owns Can Fite Biopharma?

Insider buying vs selling

Have Can Fite Biopharma Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when CANF insiders and whales buy or sell their stock.

CANF Shareholders

What type of owners hold Can Fite Biopharma Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Pnina Fishman0.00%88$126.28Insider
Sabby Management LLC0.00%85$121.98Institution
Citadel Advisors LLC0.00%26$37.31Institution
Rhumbline Advisers0.00%19$27.27Institution
Jane Street Group LLC0.00%13$18.66Institution
Guy Regev0.00%8$11.48Insider
Gamma Investing LLC0.00%6$8.61Institution
Ubs Group Ag0.00%2$2.87Institution
Citigroup Inc0.00%2$2.87Institution
Activest Wealth Management0.00%0$0.00Institution

1 of 2

CANF vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CANF0.00%0.00%
CELZ0.06%13.79%
SKYE0.00%100.00%Net SellingNet Selling
JAGX0.00%74.98%
AZTR0.11%99.89%

Can Fite Biopharma Stock Ownership FAQ

Who owns Can Fite Biopharma?

Can Fite Biopharma (NYSEMKT: CANF) is owned by 0.00% institutional shareholders, 0.00% Can Fite Biopharma insiders, and 99.99% retail investors. Pnina Fishman is the largest individual Can Fite Biopharma shareholder, owning 88.00 shares representing 0.00% of the company. Pnina Fishman's Can Fite Biopharma shares are currently valued at $126.28.

If you're new to stock investing, here's how to buy Can Fite Biopharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.